Skip to main content

Katie Hoadley, PhD

Assistant Professor, Genetics

Research Interests

Keywords: Computational Genomics, Bioinformatics, Cancer Biology, Genetics, Translational biology, RNA sequencing, TCGA

Lab Website


The Hoadley Lab is focused on understanding the biology of cancer through gene expression analyses and integrative genomic approaches. We have been long time members of The Cancer Genome Atlas (TCGA) project that has comprehensively characterized over 10,000 samples from 33 tumor types. UNC was one of the main RNA sequencing centers for the TCGA project and we participated in the gene expression analysis for many of these projects. Our group is continuing our collaborative work as a member of the NCI’s Center for Cancer Genomics new Genomic Data Analysis Network as a specialized center for RNA sequencing analysis. We will build on the experience developed in TCGA to analyze data for new NCI programs and collaborations such as the Exceptional Responders and ALCHEMIST. In addition, the group still focuses on breast cancer through projects to improve our classification of aggressive basal-like breast cancers and genomic analysis of clinical trials.

Mentor Training:

  • Bias 101
  • Faculty Mentoring Workshop for Biomedical Researchers

Training Program Affiliations:

  • Bioinformatics and Computational Biology
  • Genetics and Molecular Biology


Katie Hoadley in UNC Genetics News

Katherine Hoadley

October 14, 2021

Katie Hoadley, PhD Awarded New Grant as Part of Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative

Thanks to a $500,000 lead gift by Blue Cross and Blue Shield of North Carolina (Blue Cross NC), the Susan G. Komen and Blue Cross NC Metastatic Breast Cancer Disparities Collaborative Research Grant was awarded to a research team led by Jennifer Freedman, PhD, and Steven Patierno, PhD, of Duke Cancer Institute, and Katie Hoadley, PhD, of UNC Lineberger, who were awarded the grant to investigate how the ancestry of different populations impacts the immune response to metastatic breast cancer.

Katie Hoadley, PhD